CD4 and COVID-19: Additionally, the multivariate logistic regression analysis revealed that low CD4+ T cell count (< 156.00 cells/μl) was associated with all-cause mortality in COVID-19 patients treated with azvudine (OR = 5.860, 95% CI = 1.727–19.878, p = 0.005).